Cited by 8,029Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Open access

The SOLVD Investigators*·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250501

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less than or equal to 0.35. METHODS: Patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n = 1284) or enalapril (n = 1285) at doses of 2.5 to 20 mg per day in a double-bind trial. Approximately 90 percent of the patients were in New York Heart Association functional classes II and III. The follow-up averaged 41.4 months. RESULTS: There were 510 deaths in the placebo group (39.7 percent), as compared with 452 in the enalapril group (35.2 percent) (reduction in risk, 16 percent; 95 percent confidence interval, 5 to 26 percent; P = 0.0036). Although reductions in mortality were observed in several categories of cardiac deaths, the largest reduction occurred among the deaths attributed to progressive heart failure (251 in the placebo group vs. 209 in the enalapril group; reduction in risk, 22 percent; 95 percent confidence interval, 6 to 35 percent). There was little apparent effect of treatment on deaths classified as due to arrhythmia without pump failure. Fewer patients died or were hospitalized for worsening heart failure (736 in the placebo group and 613 in the enalapril group; risk reduction, 26 percent; 95 percent confidence interval, 18 to 34 percent; P less than 0.0001). CONCLUSIONS: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250501

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A. N., Devereux, R. B., Feigenbaum, H., Gutgesell, H. P., Reichek, N., Sahn, D. J., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,110
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Francis, G. S., Benedict, C. R., Johnstone, D. E., Kirlin, P. C., Nicklas, J. M., Liang, C., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,386

Show all 15 references

Research works printed but not linked: 1

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.

Sorted by citations

Items 201–300 of 1,027

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab154 · Cited by 586
Dilated cardiomyopathy
Jefferies, J. L., & Towbin, J. A. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62023-7 · Cited by 580
Survival of patients with a new diagnosis of heart failure: a population based study
Cowie, M., Wood, D. A., Coats, A. J. S., Thompson, S. G., Suresh, V., Poole-Wilson, P. A., & Sutton, G. C. (2000) · Heart · doi:10.1136/heart.83.5.505 · Cited by 575
Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction
Vermès, E., Tardif, J., Bourassa, M. G., Racine, N., Lévesque, S., White, M., Guerra, P. G., & Ducharme, A. (2003) · Circulation · doi:10.1161/01.cir.0000072793.81076.d4 · Cited by 575
Discharge Education Improves Clinical Outcomes in Patients With Chronic Heart Failure
Koelling, T. M., Johnson, M. L., Cody, R. J., & Aaronson, K. D. (2005) · Circulation · doi:10.1161/01.cir.0000151811.53450.b8 · Cited by 574
Evidence of Improving Prognosis in Heart Failure
Macintyre, K., Capewell, S., Stewart, S., Chalmers, J. W. T., Boyd, J., Finlayson, A. R., Redpath, A., Pell, J. P., & McMurray, J. J. V. (2000) · Circulation · doi:10.1161/01.cir.102.10.1126 · Cited by 574
What Causes Sudden Death in Heart Failure?
Tomaselli, G. F., & Zipes, D. P. (2004) · Circulation Research · doi:10.1161/01.res.0000145047.14691.db · Cited by 572
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Armenian, S. H., Hudson, M. M., Mulder, R. L., Chen, M. H., Constine, L. S., Dwyer, M., Nathan, P. C., Tissing, W. J. E., Shankar, S., Sieswerda, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70409-7 · Cited by 570
Sleep Apnea and Heart Failure
Bradley, T. D., & Floras, J. S. (2003) · Circulation · doi:10.1161/01.cir.0000061757.12581.15 · Cited by 566
Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction
Exner, D. V., Dries, D. L., DOMANSKI, M. J., & Cohn, J. N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441802 · Cited by 566
Prevention of Heart Failure
Schocken, D. D., Benjamin, E. J., Fonarow, G. C., Krumholz, H. M., Levy, D. A., Mensah, G. A., Narula, J., Stuart‐Shor, E., Young, J. B., & Hong, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.188965 · Cited by 562
Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada.
Keith, M. E., Geranmayegan, A., Sole, M. J., Kurian, R., Robinson, A., Omran, A., & Jeejeebhoy, K. N. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00101-6 · Cited by 560
Extracellular Matrix Remodeling in Heart Failure
Weber, K. T. (1997) · Circulation · doi:10.1161/01.cir.96.11.4065 · Cited by 560
A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression
Appleby, L., Warner, R., Whitton, A., & Faragher, B. E. (1997) · BMJ · doi:10.1136/bmj.314.7085.932 · Cited by 560
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 556
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association
Bozkurt, B., Aguilar, D. A., Deswal, A. M., Dunbar, S. B., Francis, G. S., Horwich, T. B., Jessup, M. L., Kosiborod, M., Pritchett, A. M., Ramasubbu, K., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000450 · Cited by 556
Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction: Systematic Overview of Individual Data From 100 000 Patients in Randomized Trials
(1998) · Circulation · doi:10.1161/01.cir.97.22.2202 · Cited by 554
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-4083 · Cited by 553
Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
Massie, B. M., & Shah, N. B. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70173-x · Cited by 547
Impact of a Comprehensive Heart Failure Management Program on Hospital Readmission and Functional Status of Patients With Advanced Heart Failure
Fonarow, G. C., Stevenson, L. W., Walden, J. A., Livingston, N., Steimle, A. E., Hamilton, M. A., Moriguchi, J. D., Tillisch, J. H., & Woo, M. A. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00208-8 · Cited by 541
Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003
Jhund, P. S., Macintyre, K., Simpson, C. R., Lewsey, J., Stewart, S., Redpath, A., Chalmers, J. W. T., Capewell, S., & McMurray, J. J. V. (2009) · Circulation · doi:10.1161/circulationaha.108.812172 · Cited by 540
Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic overview of individual data from 100,000 patients in randomized trials
Franzosi, M. G., Santoro, E., Zuanetti, G., Baigent, C., Collins, R., Flather, M. D., Kjekshus, J., Latini, R., Liu, L., Maggioni, A. P., et al. (1998) · Circulation · Cited by 536
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
HALL, S. A., Cigarroa, C. G., Marcoux, L., Risser, R. C., Grayburn, P. A., & Eichhorn, E. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00543-y · Cited by 534
Structural and Functional Remodeling of the Left Atrium
Casaclang‐Verzosa, G., Gersh, B. J., & Tsang, T. S. M. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.026 · Cited by 533
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey
Cleland, J. G. F., Solal, A. C., Aguilar, J. A. C., Dietz, R., Eastaugh, J., Folláth, F., Freemantle, N., Gavazzi, A., van Gilst, W. H., Hobbs, R. F., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11601-1 · Cited by 533
Exercise limitation in chronic heart failure: Central role of the periphery
Clark, A. L., Poole-Wilson, P. A., & Coats, A. J. S. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00323-3 · Cited by 531
Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: The Cardiovascular Health Study
Aurigemma, G. P., Gottdiener, J. S., Shemanski, L. R., Gardin, J. M., & Kitzman, D. W. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01110-x · Cited by 528
Insights from the Study of Heart Rate Variability
Stein, P. K., & Kleiger, R. E. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.249 · Cited by 525
Heart failure etiology and response tomilrinone in decompensated heart failure
Felker, G. M., Benza, R. L., Chandler, A. B., Leimberger, J. D., Cuffe, M. S., Califf, R. M., Gheorghiade, M., & O’Connor, C. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02968-6 · Cited by 521
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G. L., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C. S., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.008 · Cited by 519
Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry
Shindler, D. M., Kostis, J. B., Yusuf, S., Quinones, M. A., Pitt, B., Stewart, D., Pinkett, T., Ghali, J. K., Wilson, A. C., & The SOLVD Investigators (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89163-1 · Cited by 516
Self-citation
Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients
Page, J., & Henry, D. A. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.777 · Cited by 516
Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials
Dagenais, G. R., Pogue, J., Fox, K., Simoons, M. L., & Yusuf, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69201-5 · Cited by 514
Heart failure with mid-range or mildly reduced ejection fraction
Savarese, G., Stolfo, D., Sinagra, G., & Lund, L. H. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00605-5 · Cited by 514
Role of the Renin-Angiotensin-Aldosterone System and Proinflammatory Mediators in Cardiovascular Disease
Ferrario, C. M., & Strawn, W. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.059 · Cited by 512
Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placebo
Rector, T. S., Kubo, S. H., & Cohn, J. N. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90582-w · Cited by 509
Comparison of Surgical and Medical Group Survival in Patients With Left Main Coronary Artery Disease
Caracciolo, E. A., Davis, K. B., Sopko, G. S., Kaiser, G. C., Corley, S. D., Schaff, H. V., Taylor, H. A., & CHAITMAN, B. R. (1995) · Circulation · doi:10.1161/01.cir.91.9.2325 · Cited by 505
Titration of medical therapy for heart failure with reduced ejection fraction
Greene, S. J., Fonarow, G. C., DeVore, A. D., Sharma, P. P., Vaduganathan, M., Albert, N. M., Duffy, C. I., Hill, C. L., McCague, K., Patterson, J. H., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.015 · Cited by 500
Relationship Between Medicare’s Hospital Compare Performance Measures and Mortality Rates
Werner, R. M., & Bradlow, E. T. (2006) · JAMA · doi:10.1001/jama.296.22.2694 · Cited by 499
Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care
Mant, J., Doust, J., Roalfe, A., Barton, P., Cowie, M., Glasziou, P., Mant, D., McManus, R., Holder, R., Deeks, J., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13320 · Cited by 498
Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction
Kramer, D. G., Trikalinos, T. A., Kent, D. M., Antonopoulos, G. V., Konstam, M. A., & Udelson, J. E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.011 · Cited by 498
Depressed Heart Rate Variability as an Independent Predictor of Death in Chronic Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy
Ponikowski, P. P., Anker, S. D., Chua, T. P., Szełemej, R., Piepoli, M. F., Adamopoulos, S. N., Webb-Peploe, K., Harrington, D., Banasiak, W., Wrabec, K., et al. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00215-4 · Cited by 497
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Lonn, E., Yusuf, S., Jha, P., Montague, T. J., Teo, K. K., Benedict, C. R., & Pitt, B. (1994) · Circulation · doi:10.1161/01.cir.90.4.2056 · Cited by 497
Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy
Pedersen, O. D., Bagger, H., Keller, N., Marchant, B., Køber, L., & Torp-Pedersen, C. (2001) · Circulation · doi:10.1161/01.cir.104.3.292 · Cited by 496
American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography
Mulvagh, S. L., Rakowski, H., Vannan, M. A., Abdelmoneim, S. S., Becher, H. H., Bierig, S. M., Burns, P. N., Castelló, R., Coon, P. D., Hagen, M. E., et al. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.09.009 · Cited by 493
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status
Shekelle, P. G., Rich, M. W., Morton, S. C., Atkinson, C. S. W., Tu, W., Maglione, M., Rhodes, S., Barrett, M., Fonarow, G. C., Greenberg, B., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00262-6 · Cited by 492
Implantable Left Ventricular Assist Devices
Goldstein, D. J., Öz, M. C., & Rose, E. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392107 · Cited by 491
Post-Myocardial Infarction Heart Failure
Bahit, M. C., Kochar, A., & Granger, C. B. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2017.09.015 · Cited by 490
Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failureResults from a prospective, randomised trial
Strömberg, A. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00112-x · Cited by 483
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 483
Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
Rocha, R., Stier, C. T., Kifor, I., Ochoa-Maya, M. R., Rennke, H. G., Williams, G. H., & Adler, G. K. (2000) · Endocrinology · doi:10.1210/endo.141.10.7711 · Cited by 480
Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases
Matsubara, H. (1998) · Circulation Research · doi:10.1161/01.res.83.12.1182 · Cited by 480
Outcome of Congestive Heart Failure in Elderly Persons: Influence of Left Ventricular Systolic Function: The Cardiovascular Health Study
Gottdiener, J. S., McClelland, R. L., Marshall, R., Shemanski, L., Furberg, C. D., Kitzman, D. W., Cushman, M., Polak, J. F., Gardin, J. M., Gersh, B. J., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-8-200210150-00006 · Cited by 479
Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience.
Krischer, J. P., Epstein, S., Cuthbertson, D. D., Goorin, A. M., Epstein, M. L., & Lipshultz, S. E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1544 · Cited by 476
Effects of Vesnarinone on Morbidity and Mortality in Patients with Heart Failure
Feldman, A. M., Bristow, M. R., Parmley, W. W., Carson, P. E., Pepine, C. J., Gilbert, E. M., Strobeck, J. E., Hendrix, G., Powers, E. R., Bain, R. P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290301 · Cited by 475
Effects of Long-term Enalapril Therapy on Cardiac Structure and Function in Patients With Left Ventricular Dysfunction
Greenberg, B., Quiñones, M. A., Koilpillai, C. J., Limacher, M. C., Shindler, D. M., Benedict, C. R., & Shelton, B. J. (1995) · Circulation · doi:10.1161/01.cir.91.10.2573 · Cited by 473
Recent Progress in Angiotensin II Type 2 Receptor Research in the Cardiovascular System
Horiuchi, M., Akishita, M., & Dzau, V. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.613 · Cited by 473
The renin-angiotensin-aldosterone system and its suppression
Ames, M. K., Atkins, C. E., & Pitt, B. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15454 · Cited by 473
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients
van Vark, L. C., Bertrand, M. E., Akkerhuis, K. M., Brugts, J. J., FOX, K. L., Mourad, J., & Boersma, E. H. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs075 · Cited by 471
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., & Stevenson, W. G. (2006) · Circulation · doi:10.1161/circulationaha.106.655688 · Cited by 471
The prognosis of heart failure in the general population: the Rotterdam Study
Mosterd, A. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2533 · Cited by 470
Heart Failure and Ventricular Dysfunction in Patients With Single or Systemic Right Ventricles
Piran, S., VELDTMAN, G. R., Siu, S. C., Webb, G. D., & Liu, P. P. (2002) · Circulation · doi:10.1161/hc1002.105182 · Cited by 470
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167587 · Cited by 469
The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports
Gonseth-Garcia, J. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.04.022 · Cited by 468
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.018 · Cited by 468
Medical Management of Advanced Heart Failure
Nohria, A. (2002) · JAMA · doi:10.1001/jama.287.5.628 · Cited by 466
Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF)
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K. B., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft052 · Cited by 466
Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function
Kaschina, E., & Unger, T. (2003) · Blood Pressure · doi:10.1080/08037050310001057 · Cited by 465
Systolic Heart Failure
McMurray, J. J. V. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp0909392 · Cited by 464
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart
Eichhorn, E. J., & Bristow, M. R. (1996) · Circulation · doi:10.1161/01.cir.94.9.2285 · Cited by 461
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
Wouters, K. A., Kremer, L. C. M., Miller, T. L., Herman, E. H., & Lipshultz, S. E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05759.x · Cited by 457
Incidence and Epidemiology of Heart Failure
Kannel, W. B. (2000) · Heart Failure Reviews · doi:10.1023/a:1009884820941 · Cited by 457
Secondary Prevention After Coronary Artery Bypass Graft Surgery
Kulik, A., Ruel, M., Jneid, H. M., Ferguson, T. B., Hiratzka, L. F., Ikonomidis, J. S., López-Jiménez, F. A., McNallan, S. M., Patel, M. J., Roger, V. L., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000182 · Cited by 457
Effects of a Home-Based Intervention Among Patients With Congestive Heart Failure Discharged From Acute Hospital Care
Stewart, S., Pearson, S., & Horowitz, J. D. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.10.1067 · Cited by 456
Heart Failure: Diagnosis, Management and Utilization
Inamdar, A. A., & Inamdar, A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5070062 · Cited by 454
HFSA 2006 Comprehensive Heart Failure Practice Guideline: Introduction and Table of Contents
Heart Failure Society of America (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.11.005 · Cited by 450
Basic mechanisms in heart failure: The cytokine hypothesis
Seta, Y., Shan, K., Bozkurt, B., Oral, H., & Mann, D. L. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80047-9 · Cited by 449
Drugs targeting the renin–angiotensin–aldosterone system
Zaman, M. A., Oparil, S., & Calhoun, D. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd873 · Cited by 446
Animal models of human cardiovascular disease, heart failure and hypertrophy
Hasenfuss, G. P. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00110-2 · Cited by 443
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018
Atherton, J. J., Sindone, A. P., Pasquale, C. G. D., Driscoll, A. L., Macdonald, P. S., Hopper, I., Kistler, P. M., Briffa, T. G., Wong, J., Abhayaratna, W. P., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1042 · Cited by 439
Inpatient general medicine is evidence based
Sackett, D. L., Ellis, J., Mulligan, I., & Rowe, J. B. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92781-6 · Cited by 433
Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop)
Manolio, T. A., Baughman, K. L., Rodeheffer, R. R., Pearson, T. A., Bristow, J. D., Michels, V. V., Abelmann, W. H., & Harlan, W. R. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90901-a · Cited by 433
B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
Richards, M., Nicholls, M. G., Espiner, E. A., Lainchbury, J. G., Troughton, R. W., Elliott, J. M., FRAMPTON, C. M. A., Turner, J. G., Crozier, I., & Yandle, T. G. (2003) · Circulation · doi:10.1161/01.cir.0000070953.76250.b9 · Cited by 433
Myocyte Recovery After Mechanical Circulatory Support in Humans With End-Stage Heart Failure
Δίπλα, Κ., Mattiello, J. A., Jeevanandam, V., Houser, S. R., & Margulies, K. B. (1998) · Circulation · doi:10.1161/01.cir.97.23.2316 · Cited by 430
Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population
Hobbs, R. F. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3255 · Cited by 428
Profile for Estimating Risk of Heart Failure
Kannel, W. B., D’Agostino, R. B., Silbershatz, H., Belanger, A. J., Wilson, P. W. F., & Levy, D. A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.11.1197 · Cited by 428
Therapeutic approaches for cardiac regeneration and repair
Hashimoto, H., Olson, E. N., & Bassel‐Duby, R. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0036-6 · Cited by 428
Human pharmaceuticals in US surface waters: A human health risk assessment
Schwab, B. W., Hayes, E. P., Fiori, J. M., Mastrocco, F. J., Roden, N. M., Cragin, D., Meyerhoff, R. D., D’Aco, V. J., & Anderson, P. D. (2005) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2005.05.005 · Cited by 427
Overcoming the limitations of current meta-analysis of randomised controlled trials
Pogue, J., & Yusuf, S. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08461-4 · Cited by 427
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Desai, A. S., McMurray, J. J. V., Packer, M., Swedberg, K. B., Rouleau, J. L., Chen, F., Gong, J., Rizkala, A. R., Brahimi, A., Claggett, B. L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv186 · Cited by 426
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P. H., Alfonso, F., Collet, J., Cremer, J., Falk, V., Filippatos, G. S., Hamm, C. W., Head, S. J., Jüni, P., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0224 · Cited by 422
A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study
Kazanegra, R., Cheng, V. L., Garcia, A., Krishnaswamy, P., Gardetto, N. J., Clopton, P., & Maisel, A. S. (2001) · Journal of Cardiac Failure · doi:10.1054/jcaf.2001.23355 · Cited by 420
Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart Disease fn1fn1This study was funded by a grant from SmithKline Beecham; however, the study was initiated, conducted, analyzed and reported by the Australia–New Zealand Heart Failure Research Collaborative Group independently of the sponsor. The Clinical Trials Research Unit is supported by a programme grant from the Health Research Council of New Zealand.
Doughty, R. N., WHALLEY, G. A., Gamble, G. D., MacMahon, S. W., & Sharpe, N. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00012-0 · Cited by 419
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study
Ouwerkerk, W., Voors, A. A., Anker, S. D., Cleland, J. G. F., Dickstein, K., Filippatos, G. S., van der Harst, P., Hillege, H. L., Lang, C. C., ter Maaten, J. M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx026 · Cited by 415
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
Sousa‐Uva, M., Head, S. J., Milojevic, M., Collet, J., Landoni, G., Castellà, M., Dunning, J., Guðbjartsson, T., Linker, N., Sandoval, E., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx314 · Cited by 415
Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy
Raynolds, M. V., Bristow, M. R., Bush, E. W., Abraham, W. T., Lowes, B. D., Zisman, L. S., Taft, C. S., & Perryman, M. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92061-w · Cited by 414
Relation of Loop Diuretic Dose to Mortality in Advanced Heart Failure
Eshaghian, S., Horwich, T. B., & Fonarow, G. C. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.072 · Cited by 413
Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure
Massie, B. M., Collins, J. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Ezekowitz, M. D., Jafri, S. M., Krol, W. F., O’Connor, C. M., Schulman, K. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.801753 · Cited by 413
Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology Recommendations of the Task Force of the European Society of Cardiology
Bertrand, M. E. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2301 · Cited by 412
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management
Arnold, J. M. O., Liu, P. P., Demers, C., Dorian, P., Giannetti, N., Haddad, H. A., Heckman, G. A., Howlett, J. G., Ignaszewski, A. P., Johnstone, D. E., et al. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70237-9 · Cited by 410

Authors: The SOLVD Investigators*
Corresponding author: The SOLVD Investigators*
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 293-302
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250501
OpenAlex: W2585382523
Cited by: 8,029
References: 15
Citations by year: 2026: 78 · 2025: 89 · 2024: 117 · 2023: 152 · 2022: 174 · 2021: 167 · 2020: 182 · 2019: 174 · 2018: 174 · 2017: 187 · 2016: 211 · 2015: 208 · 2014: 165 · 2013: 168 · 2012: 231
FWCI: 170.62
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, ACE inhibitors, congestive heart failure, reduced left ventricular ejection fraction, mortality, hospitalization, heart failure progression, cardiac arrhythmias, NYHA functional class
MeSH terms: Blood Pressure, Cause of Death, Chronic Disease, Double-Blind Method, Electrolytes, Enalapril, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Kidney, Male, Middle Aged, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks